Dabigatran etexilate: a direct thrombin inhibitor
BACKGROUND Direct Thrombin Inhibitors (DTIs) represent a new and promising class of anticoagulants. Unlike heparin, they directly interact with thrombin and block fibrinogen binding. Dabigatran etexilate is becoming the most representative of the DTIs administered orally. <br />AIM OF THE REVI...
| Published in: | Italian Journal of Medicine |
|---|---|
| Main Author: | |
| Format: | Article |
| Language: | English |
| Published: |
PAGEPress Publications
2013-05-01
|
| Subjects: | |
| Online Access: | http://www.italjmed.org/index.php/ijm/article/view/350 |